Oligonucleotide-mediated triple helix formation using an N3-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range.
about
Recognition of 5-aminouracil (U(#)) in the central strand of a DNA triplex: orientation selective binding of different third strand bases.Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine.Triplex formation at physiological pH by 5-Me-dC-N4-(spermine) [X] oligodeoxynucleotides: non protonation of N3 in X of X*G:C triad and effect of base mismatch/ionic strength on triplex stabilitiesTriplex formation at physiological pH: comparative studies on DNA triplexes containing 5-Me-dC tethered at N4 with spermine and tetraethyleneoxyamineEfficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA.Triple helix DNA alters nucleosomal histone-DNA interactions and acts as a nucleosome barrierDNA triple helices: biological consequences and therapeutic potential.Unnatural nucleosides with unusual base pairing properties.Unnatural nucleosides with unusual base pairing properties.Formation of stable DNA triplexes.Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.DNA triple-helix formation at pyrimidine-purine inversion sites.2'-O,4'-C-methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH: thermodynamic and kinetic studies.The binding of an antisense oligonucleotide to a hairpin structure via triplex formation inhibits chemical and biological reactions.An anti-parallel triple helix motif with oligodeoxynucleotides containing 2'-deoxyguanosine and 7-deaza-2'-deoxyxanthosine.DNA triple helix stabilisation by a naphthylquinoline dimer.2'-O,4'-C-aminomethylene-bridged nucleic acid modification with enhancement of nuclease resistance promotes pyrimidine motif triplex nucleic acid formation at physiological pH.Interrupted 2'-o,4'-C-aminomethylene bridged nucleic acid modification enhances pyrimidine motif triplex-forming ability and nuclease resistance under physiological condition.Sequence-specific targeting and covalent modification of human genomic DNAEfficient triple helix formation by oligodeoxyribonucleotides containing alpha- or beta-2-amino-5-(2-deoxy-D-ribofuranosyl) pyridine residuesSequence composition effects on the stabilities of triple helix formation by oligonucleotides containing N7-deoxyguanosine.Use of a pyrimidine nucleoside that functions as a bidentate hydrogen bond donor for the recognition of isolated or contiguous G-C base pairs by oligonucleotide-directed triplex formationPyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.Protection of DNA sequences by triplex-bridge formation.6-Oxocytidine a novel protonated C-base analogue for stable triple helix formation.Polyamine-linked oligonucleotides for DNA triple helix formation.Poly(l-lysine)-graft-dextran Copolymer Promotes Pyrimidine Motif Triplex DNA Formation at Physiological pH
P2860
Q33615155-2F586293-EA1D-430B-9590-56EA1FF93FF1Q34590589-5F6EC8E5-A7B4-4D29-9725-9D0FD173A64DQ34593052-A3054568-16C0-4F31-A5CC-994C97586288Q34642362-25B2AA55-E781-4604-9F76-824B3C9C6AB0Q34734918-0FD42A51-7AB8-444D-B862-B540184590C3Q34756935-515D92ED-BA06-4148-A9DC-635119E8C33DQ36982332-10B86195-D2DE-4CEA-A5BA-8B020035667EQ37144627-89E5B878-12C0-4432-8C5E-ED8937375629Q37504874-CF2D56F1-516B-4D4D-AD21-FC226BB64510Q37856420-9091733C-98E0-413F-9BDD-14AF636BC920Q38288224-69934A0B-0CEB-483F-9F3D-13ED113CFE66Q38296797-BBC0C09F-1BB3-4D49-8CDF-8BCF0FAE0477Q38307544-5ABBCC91-D175-463D-8DD3-B726CD5A3439Q38313520-1F6F6595-F8DC-4B7B-B4CA-F66CB1748F04Q38322312-C93AD7A3-D435-418E-AC99-B771B1D18CB6Q38325592-2D350899-D0A5-48F9-A3FC-6FD5E8096E1BQ38337867-6F296E05-74F2-4340-96C0-8F6BA08577B0Q38337896-D3CF504D-FC95-4B60-87A5-A910F4FCBF57Q38343301-1F28E5E9-D972-4C68-B45A-49B8996E49D7Q38351751-31F0B09E-F829-483E-9B94-FD211EC03E0EQ38357204-D6CF4A73-884E-4A7C-864C-CBB3C4FCB54DQ39716290-37CD0EB4-A6BF-4429-9D95-D30334BD32C2Q40230335-BC5D286D-D990-4DFF-8F42-6E27AF83BE85Q40392876-8BC05CCD-511D-4FAF-88E3-B1BD001A414FQ40395664-62AF64B3-39DA-47C8-9B56-2F730FB4D26BQ40412730-717577BB-E496-4A1B-9D75-5172921C7A7AQ57744114-82065E79-9586-4A24-A44B-E301F1F29834
P2860
Oligonucleotide-mediated triple helix formation using an N3-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@en
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@nl
type
label
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@en
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@nl
prefLabel
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@en
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@nl
P2093
P2860
P356
P1476
Oligonucleotide-mediated tripl ...... ithin the physiological range.
@en
P2093
Froehler BC
Krawczyk SH
Matteucci MD
Milligan JF
P2860
P304
P356
10.1073/PNAS.89.9.3761
P407
P577
1992-05-01T00:00:00Z